BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19339093)

  • 1. Solute clearances and fluid removal in the frequent hemodialysis network trials.
    Greene T; Daugirdas JT; Depner TA; Gotch F; Kuhlman M; ; ;
    Am J Kidney Dis; 2009 May; 53(5):835-44. PubMed ID: 19339093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics and dosing predictions for daily haemofiltration.
    Leypoldt JK; Jaber BL; Lysaght MJ; McCarthy JT; Moran J
    Nephrol Dial Transplant; 2003 Apr; 18(4):769-76. PubMed ID: 12637647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standard Kt/Vurea: a method of calculation that includes effects of fluid removal and residual kidney clearance.
    Daugirdas JT; Depner TA; Greene T; Levin NW; Chertow GM; Rocco MV;
    Kidney Int; 2010 Apr; 77(7):637-44. PubMed ID: 20107428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solute kinetics with short-daily home hemodialysis using slow dialysate flow rate.
    Kohn OF; Coe FL; Ing TS
    Hemodial Int; 2010 Jan; 14(1):39-46. PubMed ID: 19758296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of increased frequency of hemodialysis on serum cystatin C and β2-microglobulin concentrations: A secondary analysis of the frequent hemodialysis network (FHN) trial.
    Huang SS; Kaysen GA; Levin NW; Kliger AS; Beck GJ; Rocco MV; Filler G; Lindsay RM;
    Hemodial Int; 2019 Jul; 23(3):297-305. PubMed ID: 30861262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adequacy of quotidian hemodialysis.
    Suri R; Depner TA; Blake PG; Heidenheim AP; Lindsay RM
    Am J Kidney Dis; 2003 Jul; 42(1 Suppl):42-8. PubMed ID: 12830443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantifying the effect of changes in the hemodialysis prescription on effective solute removal with a mathematical model.
    Clark WR; Leypoldt JK; Henderson LW; Mueller BA; Scott MK; Vonesh EF
    J Am Soc Nephrol; 1999 Mar; 10(3):601-9. PubMed ID: 10073611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline characteristics of participants in the Frequent Hemodialysis Network (FHN) daily and nocturnal trials.
    Rocco MV; Larive B; Eggers PW; Beck GJ; Chertow GM; Levin NW; Kliger AS;
    Am J Kidney Dis; 2011 Jan; 57(1):90-100. PubMed ID: 21122961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The variable target model: a paradigm shift in the incremental haemodialysis prescription.
    Casino FG; Basile C
    Nephrol Dial Transplant; 2017 Jan; 32(1):182-190. PubMed ID: 27742823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 6-times-weekly versus 3-times-weekly hemodialysis on depressive symptoms and self-reported mental health: Frequent Hemodialysis Network (FHN) Trials.
    Unruh ML; Larive B; Chertow GM; Eggers PW; Garg AX; Gassman J; Tarallo M; Finkelstein FO; Kimmel PL;
    Am J Kidney Dis; 2013 May; 61(5):748-58. PubMed ID: 23332990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term Effects of Frequent Nocturnal Hemodialysis on Mortality: The Frequent Hemodialysis Network (FHN) Nocturnal Trial.
    Rocco MV; Daugirdas JT; Greene T; Lockridge RS; Chan C; Pierratos A; Lindsay R; Larive B; Chertow GM; Beck GJ; Eggers PW; Kliger AS;
    Am J Kidney Dis; 2015 Sep; 66(3):459-68. PubMed ID: 25863828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small-solute and middle-molecule clearances during continuous flow peritoneal dialysis.
    Leypoldt JK; Burkart JM
    Adv Perit Dial; 2002; 18():26-31. PubMed ID: 12402582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short daily and nocturnal hemodialysis: new therapies for a new century?
    Rocco MV
    Saudi J Kidney Dis Transpl; 2009 Jan; 20(1):1-11. PubMed ID: 19112213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneal dialysis kinetic modeling: validation in a multicenter clinical study.
    Vonesh EF; Burkart J; McMurray SD; Williams PF
    Perit Dial Int; 1996; 16(5):471-81. PubMed ID: 8914177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volume of urea cleared as a therapy dosing guide for more frequent hemodialysis.
    Leypoldt JK; Weinhandl ED; Collins AJ
    Hemodial Int; 2019 Jan; 23(1):42-49. PubMed ID: 30255600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small and middle molecular weight solute clearance in nocturnal intermittent peritoneal dialysis.
    Brophy DF; Sowinski KM; Kraus MA; Moe SM; Klaunig JE; Mueller BA
    Perit Dial Int; 1999; 19(6):534-9. PubMed ID: 10641773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritoneal urea and creatinine clearances in continuous peritoneal dialysis patients with different types of peritoneal solute transport.
    Tzamaloukas AH; Murata GH; Piraino B; Rao P; Bernardini J; Malhotra D; Oreopoulos DG
    Kidney Int; 1998 May; 53(5):1405-11. PubMed ID: 9573559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urea kinetic analysis of automated peritoneal dialysis allows calculation of a CAPD-equivalent Kt/V(urea).
    Schurman SJ; Shoemaker LR; Warady BA
    Kidney Int; 2000 Sep; 58(3):1318-24. PubMed ID: 10972696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of methods to calculate dialysis dose in daily hemodialysis].
    Maduell F; Gutiérrez E; Navarro V; Torregrosa E; Martínez A; Rius A
    Nefrologia; 2003; 23(4):344-9. PubMed ID: 14558334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of treatment frequency on haemodialysis dose: comparison of EKR and stdKt/V.
    Vartia A
    Nephrol Dial Transplant; 2009 Sep; 24(9):2797-803. PubMed ID: 19386748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.